See All Slides -

Slides

Presentation TCT 2012

TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from...

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

ELM Presentation(6)

Presenter: Lynn Peng

October 23, 2012

Presentation TCT 2012

New Devices in the Old World: A European View of Device Development for Heart Failure

Presenter: Stefan Anker

October 23, 2012

Presentation TCT 2012

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

TCT-36. Circumferential Distribution of the Neointima Tissue at 6 Months and 2 at Years Follow-up After a Bioresorbable Scaffold Implantation: A Serial Optical Coherence...

Presenter: Christos Bourantas

October 23, 2012

Presentation TCT 2012

TCT-85. Efficacy and Safety of Percutaneous Patent Foramen Ovale Closure in Patients with a Hypercoagulable Disorder

Presenter: Ignacio Cruz-Gonz?lez

October 23, 2012

Presentation TCT 2012

Radial Approach Offers No Benefit Over Femoral Plus Bivalirudin!

Presenter: James Hermiller Jr

October 23, 2012

Presentation TCT 2012

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Pro!

Presenter: Thomas Zeller

October 23, 2012

Presentation TCT 2012

CABG Will Always Be the Preferred Approach!

Presenter: Friedrich Mohr

October 23, 2012

Presentation TCT 2012

Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress

Presenter: Timothy Henry

October 23, 2012

Advertisement

Slides

TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from...

ELM Presentation(6)

New Devices in the Old World: A European View of Device Development for Heart Failure

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

TCT-36. Circumferential Distribution of the Neointima Tissue at 6 Months and 2 at Years Follow-up After a Bioresorbable Scaffold Implantation: A Serial Optical Coherence...

TCT-85. Efficacy and Safety of Percutaneous Patent Foramen Ovale Closure in Patients with a Hypercoagulable Disorder

Radial Approach Offers No Benefit Over Femoral Plus Bivalirudin!

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Pro!

CABG Will Always Be the Preferred Approach!

Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content